BAP Pharma

What BAP Pharma does

BAP Pharma is a UK-headquartered clinical trial supply and medicines access company founded in 2011 by Dr. Bashir Parkar. The company provides four integrated services — comparator sourcing, secondary clinical packaging and labelling, medicines access (Early Access, Named Patient, Compassionate Use, and Post-Trial Access), and temperature-controlled storage and distribution — to pharmaceutical sponsors and biotech companies conducting global clinical trials. It operates purpose-built, fully licensed facilities in Marlow (UK, headquarters), Höchstädt an der Donau (Germany), and Somerset, New Jersey (USA, 28,000 sq. ft.), combined with a hand-picked global depot network reaching 100+ countries. Customer segments are enterprise-focused, comprising large pharmaceutical companies and Phase 2/3 biotech innovators, with a distinct exclusive global partnership with Agenus Inc. (announced April 2026) for BOT+BAL immuno-oncology access programs.

The technology stack is operational rather than AI-led. The proprietary EQMS (E-Quality Management System) is a custom electronic quality management system built to reflect the complexities of global clinical supply chains and ensure compliant service delivery. The BAP Portal is a dedicated regulated platform that allows registered healthcare professionals to submit and track patient requests under Early Access, Named Patient, and Managed Access Programs. The company holds MHRA GMP/GDP authorization (UK), Bavarian Health Authority authorization (Germany), and New Jersey Department of Health licensing with FDA Establishment Registration (US), plus a UK Home Office Controlled Drugs Licence covering Schedules 1-5 and ISO9001:2015 certification.

Revenue is generated through project-based B2B service contracts priced on volume, geographic scope, regulatory complexity, and service components, with multi-year contract cadences. Go-to-market is enterprise field sales with dedicated business development teams in the UK, Germany, and US, supplemented by an active presence at major industry conferences (CPHI, ESMO, BIO Europe, Outsourcing in Clinical Trials, ISPOR, ASH). The company is fully privately owned by Dr. Bashir Parkar and Mrs. Nafisa Parkar with no outside investors, and is celebrating 15 years of operations.

Name

BAP Pharma

Legal name

BAP Pharma Group Limited

Website

https://bappharma.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

BAP Pharma is a UK-headquartered clinical trial supply company providing comparator sourcing, secondary packaging and labelling, medicines access, and temperature-controlled storage and distribution to pharmaceutical and biotech sponsors across 100+ countries.

Ownership category

akta.pro rank

Product category

Clinical Trial Supply Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

Keywords

• Clinical trial supply
• Comparator sourcing
• Pharmaceutical packaging
• Medicines access programs
• Cold chain distribution

Headquarters

HQ city

Marlow

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Comparator Sourcing Services: Sourcing and procurement of comparator drugs and reference products for clinical trials. Revenue generated through service fees for sourcing, verification, and procurement of medicinal products.
2. Secondary Packaging and Labelling: Clinical secondary packaging and labelling services for multi-country trials including in-house label design, print, and temperature-controlled packaging operations.
3. Medicines Access Programs: Coordination and management of global access programs including Early Access Programs, Compassionate Use, Named Patient Programs, and Post-Trial Access. Services include program requests, case coordination, distribution logistics, and payment processing.
4. Storage and Distribution: Temperature-controlled storage and global distribution services for clinical trial supplies, including cold chain logistics and regulatory-compliant distribution to clinical sites worldwide.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

BAP Pharma provides integrated clinical trial supply services to pharmaceutical and biotech sponsors, including comparator drug sourcing, secondary clinical packaging and labelling, temperature-controlled storage and distribution, and medicines access programs (Early Access, Named Patient, Compassionate Use, and Post-Trial Access). The company operates purpose-built, GMP/GDP-licensed facilities in the UK, Germany, and USA, supported by a global depot network spanning more than 80–100 countries.

Product overview

BAP Pharma is a clinical trial supply and medicines access company offering an integrated portfolio of four core services: Comparator Sourcing (procurement of comparator drugs for clinical trials), Secondary Clinical Packaging and Labelling (multi-language labelling and blind packaging), Medicines Access (managed access programs, expanded access, named patient supply), and Storage & Distribution (temperature-controlled global logistics). The company operates the BAP Portal as a dedicated platform for healthcare professionals to manage patient access requests. A custom EQMS system underpins quality operations across all services. The company was founded in 2011 and operates facilities in the UK, Germany, and USA, supporting clinical trials in over 100 countries.

Differentiator

Problem solved

Functional benefit

Products and services

• Comparator Sourcing Sourcing and procurement of comparator drugs and reference products for global and local clinical trials, delivered with a consultative approach and innovative proposals. For pharmaceutical and biotech sponsors requiring comparator supplies for Phase II/III studies.
• Secondary Clinical Packaging and Labelling Adaptable, robust secondary clinical packaging and labelling solutions for multi-country trials, including in-house label design, print, temperature-controlled packaging, and version control. For pharmaceutical and biotech sponsors running global clinical trials.
• Medicines Access Coordination of global medicines access programs, including Early Access Programs, Compassionate Use, Named Patient Programs, and Post-Trial Access, with program requests, case coordination, distribution logistics, and payment processing. For pharmaceutical/biotech sponsors and patients with serious or life-threatening conditions.
• Storage & Distribution International temperature-controlled storage and global distribution services for clinical trial supplies, including ambient (+15°C to +25°C), cold (+2°C to +8°C), and freezer (-20°C) capabilities at purpose-built facilities, with global distribution to 100+ countries. For pharmaceutical and biotech sponsors and medicines access program clients.
• BAP Portal Dedicated regulated portal enabling registered healthcare professionals to submit, track, and manage patient requests for medicines access through Early Access, Named Patient, and Managed Access Programs, with real-time status tracking and streamlined coordination. For registered physicians treating patients with serious or life-threatening conditions.

Quantifiable outcome

• End-to-end recovery delivered in under 7 days across 17 clinical sites in Turkey
• +3 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Agenus Inc.coreStrategic or Co-development Partner · 21 April 2026Exclusive global partnership for BOT+BAL (botensilimab plus balstilimab) access programs. BAP Pharma coordinates global access program operations including program requests, case coordination, distribution logistics, and payment processing. Programs include France's Autorisation d'Accès Compassionnel (AAC) pathway and paid named-patient programs in select countries. BAP Pharma serves as the exclusive partner for Agenus, strengthening infrastructure behind these programs and reinforcing commitment to responsible patient access.

Scale indicators8 records

Recent moves13 records

Expansion highlights6 records

Direct peers

• Marken (UPS Healthcare): Specialist clinical trial logistics provider within UPS Healthcare, offering temperature-controlled storage and global distribution for investigational medicinal products — directly comparable to BAP's Storage & Distribution business.
• Clinigen Group: Direct peer; Clinigen runs a clinical trial supply business alongside a leading managed access (Early Access / Named Patient) programme operation, competing head-on with BAP Pharma's medicines access and comparator sourcing services.
• PCI Pharma Services: Contract provider of clinical trial packaging, labelling, storage, and global distribution services; competes with BAP in secondary packaging and clinical supply chain management.
• World Courier (Cencora): Specialty pharma logistics provider within Cencora (AmerisourceBergen), offering GDP-compliant cold-chain clinical trial supply and patient access distribution globally — closely comparable to BAP's GMP/GDP-licensed depot model.
• Myonex: US-headquartered clinical trial supply specialist offering comparator sourcing, packaging, labelling, and global distribution — a closely comparable mid-sized peer to BAP.
• Almac Group: Privately held clinical services provider offering comparator sourcing, clinical packaging, labelling, and global distribution — directly overlapping with all four of BAP Pharma's core service lines.
• Sharp Services (SGS): Clinical packaging, labelling, and distribution services business (now part of SGS), competing with BAP's Secondary Clinical Packaging and Labelling offering for biotech and pharma sponsors.

Regional players

• Eurofins CDMO: European-headquartered CDMO with clinical trial supply and distribution capabilities adjacent to BAP's UK and Germany operations, primarily serving EU-based biotech and pharma sponsors.

Broad incumbents

• Thermo Fisher PPD Clinical Trial Supplies: CRO/CDMO offering integrated clinical trial supply services within a global clinical research platform; competes with BAP for large multi-country trial logistics and packaging contracts.
• IQVIA (Clinical Trial Supplies): Large CRO with a dedicated clinical trial supplies unit covering comparator sourcing, packaging, labelling, and global distribution. Broader portfolio than BAP but directly overlapping.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@bappharma7755
• LinkedInlinkedin.com/company/bap-pharma

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BAP Pharma